GlassScriptPhysician profile
Thomas J Cullinane
NPI 1669546354
$5,745.45
in general payments reported to CMS, 2019-2025
20 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $661 · 2021: $912 · 2022: $1,118 · 2023: $1,003 · 2024: $688 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842 · Entertainment: $42.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,842.13 |
| Entertainment | $42.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,215.67 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $899.35 | 2022-2025 | Infuse, Biotrue One Day, Xiidra |
| Alcon Vision LLC | $881.80 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $879.73 | 2019-2021 | |
| Coopervision INC. | $838.69 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Onefit Contact Lens |
| Allergan, INC. | $261.19 | 2019-2022 | |
| Lkc Technologies, INC. | $129.75 | 2023-2025 | |
| Horizon Therapeutics Plc | $126.68 | 2021 | |
| Shire North American Group INC | $106.45 | 2019 | |
| Sun Pharmaceutical Industries INC. | $74.63 | 2021-2024 | Cequa |
| Dompe US, INC. | $50.46 | 2023-2025 | Oxervate |
| Optos, INC. | $42.99 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $40.79 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $39.74 | 2022 | |
| Abb Con-Cise Optical Group LLC | $34.79 | 2023 | Contact Lens, Spectacle Lenses |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $31.15 | 2021 | |
| Thea Pharma INC. | $25.21 | 2023 | |
| Novartis Pharmaceuticals Corporation | $24.44 | 2020 | |
| Kala Pharmaceuticals, INC. | $22.54 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Cullinane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.